Clinical Trials Directory

Trials / Completed

CompletedNCT01379651

Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy

Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Ospedale Buon Consiglio Fatebenefratelli · Academic / Other
Sex
All
Age
5 Years – 11 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.

Detailed description

Oral immunotherapy consisted in the administration of increasing amounts of raw emulsion egg. The children started with 1 drop of undiluted raw egg emulsion (0.05 ml) flavored with vanilla and cacao, hidden by the parents in the child's breakfast (cow's milk, soymilk, fruit juice or other). The dose was doubled at intervals of about one month in the day hospital. The increases in dose were customized for each subject based on the frequency and severity of side effects, or when an inter-current illness or asthma worsening intervened during the SOTI. The investigators limited the SOTI protocol to six months for all patients, irrespective of the dose reached, in order to favor the adherence of families to the study. When objective symptoms seemed more important (grade 2, 3 and 4 reaction), medical treatment was given. Subjects were discontinued from the study in case of severe adverse reactions (grade 5 reaction). Parents were advised they could telephone investigators 24 hours a day

Conditions

Interventions

TypeNameDescription
OTHERSpecific oral tolerance inductionSpecific oral tolerance induction consisted in the administration of increasing amounts of raw emulsion egg

Timeline

Start date
2008-01-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2011-06-23
Last updated
2011-09-20
Results posted
2011-08-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01379651. Inclusion in this directory is not an endorsement.